These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24741507)

  • 1. Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors.
    Kalra S; Chadha M; Sharma SK; Unnikrishnan AG
    Indian J Endocrinol Metab; 2014 Mar; 18(2):138-41. PubMed ID: 24741507
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha glucosidase inhibitors.
    Kalra S
    J Pak Med Assoc; 2014 Apr; 64(4):474-6. PubMed ID: 24864650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-glucosidase inhibitors from plants: A natural approach to treat diabetes.
    Kumar S; Narwal S; Kumar V; Prakash O
    Pharmacogn Rev; 2011 Jan; 5(9):19-29. PubMed ID: 22096315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes.
    Teng H; Chen L
    Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3438-3448. PubMed ID: 26854322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationships of Natural and Synthetic Indole-Derived Scaffolds as α-Glucosidase Inhibitors: A Mini-Review.
    Wang J; Lu S; Sheng R; Fan J; Wu W; Guo R
    Mini Rev Med Chem; 2020; 20(17):1791-1818. PubMed ID: 32560604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
    Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
    Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting α -(1,4)-Glucosidase in Diabetes Mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors.
    Figueroa-Benavides C; Matos MJ; Peñaloza-Amion M; Veas R; Valenzuela-Barra G; Zapata G; Delogu G; Uriarte E; Santana L; Olea-Azar C; Delporte C
    Curr Top Med Chem; 2018; 18(27):2327-2337. PubMed ID: 30499400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPTLC Bioautography Guided Isolation of α-Glucosidase Inhibiting Compounds from Justicia secunda Vahl (Acanthaceae).
    Theiler BA; Istvanits S; Zehl M; Marcourt L; Urban E; Caisa LO; Glasl S
    Phytochem Anal; 2017 Mar; 28(2):87-92. PubMed ID: 27910158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack.
    Ghani U
    Eur J Med Chem; 2015 Oct; 103():133-62. PubMed ID: 26344912
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zafar M; Khan H; Rauf A; Khan A; Lodhi MA
    Front Endocrinol (Lausanne); 2016; 7():153. PubMed ID: 28066324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular Complications of Diabetes: Alpha Glucosidase Inhibitor as Potential Therapy.
    Patel SS
    Horm Metab Res; 2016 Feb; 48(2):83-91. PubMed ID: 26575305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial.
    Yokoh H; Kobayashi K; Sato Y; Takemoto M; Uchida D; Kanatsuka A; Kuribayashi N; Terano T; Hashimoto N; Sakurai K; Hanaoka H; Ishikawa K; Onishi S; Yokote K
    J Diabetes Investig; 2015 Mar; 6(2):182-91. PubMed ID: 25802726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of α-glucosidase inhibitors from Cortex Lycii based on a bioactivity-labeling high-resolution mass spectrometry-metabolomics investigation.
    Liu Y; Zheng W; Zhong Y; Zhang L; Su T; Liang G; Zhang D; Zhang Y; Chen J; Gong M
    J Chromatogr A; 2021 Apr; 1642():462041. PubMed ID: 33721816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and screening strategies for alpha-glucosidase inhibitors based on enzymological information.
    Hakamata W; Kurihara M; Okuda H; Nishio T; Oku T
    Curr Top Med Chem; 2009; 9(1):3-12. PubMed ID: 19199993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening α-glucosidase inhibitors from mulberry extracts via DOSY and relaxation-edited NNR.
    Shang Q; Xiang JF; Tang YL
    Talanta; 2012 Aug; 97():362-7. PubMed ID: 22841093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of α-glucosidase inhibitors from Potentilla kleiniana Wight et Arn using solvent and flow-rate gradient high-speed counter-current chromatography target-guided by ultrafiltration HPLC-MS screening.
    Liu M; Huang X; Liu Q; Li X; Chen M; Zhu Y; Chen X
    Phytochem Anal; 2019 Nov; 30(6):661-668. PubMed ID: 31059189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and determination for potential α-glucosidase inhibitors from leaves of Acanthopanax senticosus harms by using UF-LC/MS and ESI-MS(n).
    Zhou H; Xing J; Liu S; Song F; Cai Z; Pi Z; Liu Z; Liu S
    Phytochem Anal; 2012; 23(4):315-23. PubMed ID: 21953783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.
    Heydari Z; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Ranjbar PR; Larijani B
    Med Chem; 2019; 15(1):8-16. PubMed ID: 29807519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.